GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Xianju Pharmaceutical Co Ltd (SZSE:002332) » Definitions » Accounts Payable & Accrued Expense

Zhejiang Xianju Pharmaceutical Co (SZSE:002332) Accounts Payable & Accrued Expense : ¥879 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zhejiang Xianju Pharmaceutical Co Accounts Payable & Accrued Expense?

Zhejiang Xianju Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥896 Mil) to Dec. 2023 (¥841 Mil) but then increased from Dec. 2023 (¥841 Mil) to Mar. 2024 (¥879 Mil).

Zhejiang Xianju Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥927 Mil) to Dec. 2022 (¥772 Mil) but then increased from Dec. 2022 (¥772 Mil) to Dec. 2023 (¥841 Mil).

Zhejiang Xianju Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Zhejiang Xianju Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Xianju Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Zhejiang Xianju Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 908.17 996.96 926.54 772.12 841.37

Zhejiang Xianju Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 827.69 894.00 896.23 841.37 878.71

Zhejiang Xianju Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Zhejiang Xianju Pharmaceutical Co (SZSE:002332) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Xianju Pharmaceutical Co Ltd (SZSE:002332) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
SZSE:002020 SHSE:600195 SZSE:301246 SHSE:605507 SZSE:002099 SZSE:002424 SZSE:000756 SZSE:002581 SHSE:603567 SZSE:002219 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 1 Xianyue Road, Xianju County, Zhejiang Province, CHN, 317300
Website
http://www.xjpharma.com
Zhejiang Xianju Pharmaceutical Co Ltd is a China-based company engaged in the production and sale of drugs. It mainly produces corticosteroids, sex hormones (gynecology and family planning drugs) and anesthesia and muscle relaxants.

Zhejiang Xianju Pharmaceutical Co (SZSE:002332) Headlines

No Headlines